product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Evi-1 (C50E12) Rabbit mAb
catalog :
2593S
quantity :
100 ul
price :
235 USD
clonality :
monoclonal
host :
rabbit
reactivity :
human
application :
western blot, immunocytochemistry, immunoprecipitation, flow cytometry
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/DilutionReference
Tanaka M, Suzuki H, Shibahara J, Kunita A, Isagawa T, Yoshimi A, et al. EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis. Oncogene. 2014;33:2454-63 pubmed publisher
Rommer A, Steinmetz B, Herbst F, Hackl H, Heffeter P, Heilos D, et al. EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells. PLoS ONE. 2013;8:e56308 pubmed publisher
Goyama S, Yamamoto G, Shimabe M, Sato T, Ichikawa M, Ogawa S, et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell. 2008;3:207-20 pubmed publisher
product information
SKU :
2593S
Product-Name :
Evi-1 (C50E12) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Flow cytometry
Product-Category :
Immunology and Inflammation
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
105, 145, 200
Host :
Rabbit
Target :
Evi-1
Primary-Protein :
PRDM3
Alt-Names :
AML1-EVI-1 fusion partner,EVI-1,EVI1,Ecotropic virus integration site 1 protein homolog,MDS1,MDS1 and EVI1 complex locus,MDS1 and EVI1 complex locus protein EVI1,MDS1 and EVI1 complex locus protein MDS1,MDS1-EVI1,MECOM,MGC163392,MGC97004,PRDM3,ecotropic viral integration site 1,myelodysplasia syndrome 1 protein,myelodysplasia syndrome-associated protein 1,oncogene EVI1,zinc finger protein Evi1
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.